The Medicines and Healthcare products Regulatory Agency (MHRA) and the British Generic Manufacturers Association (BGMA) have completed a "ground-breaking" partnership project aimed at reducing cost ...

The UK’s voluntary system of revenue rebates to limit rises in medicines spending is already causing deep upset among branded drug manufacturers as clawbacks rise. Now, producers of generic medicines ...

The High Court has issued a judgment on the judicial review brought by the British Generic Manufacturers Association (BGMA) dismissing the claim that the organisation was improperly excluded from the ...

Among those celebrating today’s agreement on a voluntary rebate scheme for branded medicines in the UK, there are dissenting voices, including a group representing manufacturers of off-patent ...

The British Generic Manufacturers Association (BGMA) is seeking a judicial review of the Department of Health and Social Care’s (DHSC) decision to negotiate a new Voluntary Scheme for branded ...

The United Kingdom (UK) 2019 Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) will end on 31 Dec. 2023. The UK’s 2019 VPAS succeeded several Pharmaceutical Price Regulation Schemes ...

Hormone replacement therapy, contraception and antibiotics are among vital drugs being hit by supply issues, according to reports. The British Generic Manufacturers Association has raised an alarm, ...